We have characterized a population of chemoresistant glioma cells in which AKT is activated through the binding of IGF2 to IGF-1R and indirectly repressed by IGFB6 secreted from chemosensitive glioma cells. This evidence concerns the gene AKT1 and central nervous system cancer.